Clinical trial
Screening for Early Detection and Prevention of Pompe Disease in Israel Using Tandem Mass Spectrometry
NCT01409486 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Early Detection and Prevention of Pompe Disease in Israel Using Tandem Mass Spectrometry
- Lead sponsor
- Rambam Health Care Campus
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2011
- Completion date
- September 30, 2013
- Enrollment
- 10,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pompe disease